Chemoinformaics analysis of LINARIONOSIDE A
| Molecular Weight | 374.474 | nRot | 6 |
| Heavy Atom Molecular Weight | 340.202 | nRig | 12 |
| Exact Molecular Weight | 374.23 | nRing | 2 |
| Solubility: LogS | -2.207 | nHRing | 1 |
| Solubility: LogP | 1.223 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 60.015 |
| nHD | 5 | BPOL | 37.581 |
| QED | 0.429 |
| Synth | 4.422 |
| Natural Product Likeliness | 2.507 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.107 |
| Pgp-sub | 0.897 |
| HIA | 0.422 |
| CACO-2 | -5.266 |
| MDCK | 0.0000977 |
| BBB | 0.101 |
| PPB | 0.801065 |
| VDSS | 1.29 |
| FU | 0.167844 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.089 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.518 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.343 |
| CYP2d6-inh | 0.007 |
| CYP2d6-sub | 0.118 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.085 |
| CL | 2.306 |
| T12 | 0.741 |
| hERG | 0.016 |
| Ames | 0.508 |
| ROA | 0.023 |
| SkinSen | 0.086 |
| Carcinogencity | 0.234 |
| EI | 0.071 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.033 |
| Antiviral | Yes |
| Prediction | 0.762268 |